The findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Engels N. Obi, BPharm, PhD
Advertisement
Articles by Engels N. Obi, BPharm, PhD
Advertisement
Latest Updated Articles
- Pharmacotherapy Timing in Heart Failure and Impact on Healthcare Costs
November 16th 2017
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5